Richmond, CA, United States of America

Annemarie Ledeboer

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Sangamo Therapeutics, Inc., The General Hospital Corporation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annemarie Ledeboer. Retrieved from https://idiyas.com/inventor/annemarie-ledeboer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Annemarie Ledeboer: Innovator in Alzheimer's Disease Research

Introduction

Annemarie Ledeboer is a prominent inventor based in Richmond, CA (US). She has made significant contributions to the field of diagnostics and therapeutics for Alzheimer's Disease. Her innovative work has led to the development of a patent that addresses critical challenges in this area.

Latest Patents

Annemarie holds a patent for "Tau modulators and methods and compositions for delivery thereof." This patent focuses on novel approaches to diagnosing and treating Alzheimer's Disease, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Annemarie has worked with notable organizations, including Sangamo Therapeutics, Inc. and The General Hospital Corporation. Her experience in these companies has enriched her expertise and contributed to her innovative endeavors.

Collaborations

Annemarie has collaborated with talented individuals such as Bryan Zeitler and H. Steve Zhang. These partnerships have fostered a creative environment that has led to groundbreaking advancements in her field.

Conclusion

Annemarie Ledeboer's work exemplifies the impact of innovation in addressing complex health issues like Alzheimer's Disease. Her contributions continue to inspire future research and development in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…